Stereotaxis Strengthens Board Of Directors With Appointment Of Nachum Shamir

By Author: Orson Amiri
Total Articles: 401
Comment this article

Stereotaxis (NYSE: STXS), a leader in surgical robotics for minimally invasive endovascular intervention, has appointed Nachum "Homi" Shamir to its Board of Directors. Mr. Shamir brings significant experience from his tenure as Chairman and CEO of Luminex Corporation, which he led to a $1.8 billion acquisition by DiaSorin S.p.A. in 2021. His previous roles include President and CEO of Given Imaging, acquired by Covidien for $1 billion in 2014. Currently, he serves as Chairman of Mediwound and SSI Diagnostica, adding substantial expertise in scaling high-technology medical device operations and executing mergers and acquisitions.

Mr. Shamir expressed his enthusiasm for joining Stereotaxis, praising the company's strategy and potential for growth. David Fischel, Chairman and CEO of Stereotaxis, welcomed Shamir's appointment, highlighting the value of his expertise to the company's ambitious strategy. Stereotaxis focuses on developing and delivering innovative robotic systems for the interventional laboratory, enhancing patient care, and expanding access to minimally invasive therapy. For more information, visit www.stereotaxis.com.

Read More - https://www.techdogs.com/tech-news/globe-newswire/stereotaxis-strengthens-board-of-directors-with-appointment-of-nachum-shamir